AstraZeneca (NYSE:AZN) is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the top five pharmaceutical companies in the world with healthcare sales of over $18.8 billion and leading positions in sales of gastrointestinal, oncology, cardiovascular, neuroscience and respiratory products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global and European) as well as the FTSE4Good Index. Worldwide, AstraZeneca has six major research and development sites, four discovery facilities and a clinical research site.

Since 1886, the Johnson & Johnson Family of Companies continue to provide innovative health care products that improve or save lives. A shared system of values, known as Our Credo, serves as a guide for all who are part of the Johnson & Johnson Family of Companies and can be found in 36 languages. Our Corporate Contributions program serves as a lifeline for Social Responsibility initiatives in communities in which we live and work around the world. In addition, our worldwide Environmental Commitment demonstrates how we live up to our Credo responsibility to protect our natural resources.

At the heart of Daiichi Sankyo is the fundamental belief that each employee helps shape our success. We have created an exceptional working environment that values and rewards individual contributions, but we also believe in the power of collaboration. We provide employees with the training, tools, and technology that they need to excel. Our open communication, emphasis on results, and spirit of personal accountability are hallmarks of our corporate culture and ensure that each employee's unique abilities are valued and utilized. Daiichi Sankyo, Inc., headquartered in Parsippany, New Jersey, is the U.S. subsidiary of Daiichi Sankyo Co., Ltd., Japan�s second largest pharmaceutical company and a global leader in pharmaceutical innovation since 1899. At Daiichi Sankyo, we believe that good science walks hand-in-hand with humanity. The company is dedicated to the discovery, development and commercialization of innovative medicines that improve the lives of patients throughout the world.

Medtronic is the world leader in medical technology providing lifelong solutions for people with chronic disease. We offer products, therapies and services that enhance or extend the lives of millions of people. Each year, 5 million patients benefit from Medtronic's technology, used to treat conditions such as diabetes, heart disease, neurological disorders, and vascular illnesses. At Medtronic, we push the boundaries of technology everyday. Everything we do is deeply rooted in our mission—to alleviate pain, restore health, and extend life. Our passion for life has made us the world’s leading medical technology company providing lifelong solutions to people with chronic disease. As we strive to restore people to healthy lives through medical innovation, we also are committed to the Total Well-Being of our employees and provide outstanding benefits and opportunities. At Medtronic, you can work with the kind of people who not only love what they do, but why they do it. Join Medtronic…and experience your career with a passion for life.

We are a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Our products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Our comprehensive line of products encircles life itself – addressing important health needs from infancy to the golden years. Throughout our 100+ year history, Abbott people have been driven by a constant goal: to advance medical science to help people live healthier lives. It’s part of our heritage. And, it continues to drive our work. Today, 65,000 Abbott employees around the world share the passion for "Turning Science Into Caring." It's a commitment to focusing on what matters most: life and the potential it holds when we are feeling our best.

Astellas is the brightest spot in the pharmaceutical industry; not only because of what we do, but also how we do it. If you are looking for a company where you can change a life, make a dream come true and light the way for a changing tomorrow, Astellas is the place where you can shine! At Astellas, we are driven by our core competencies of a High Sense of Ethics, Customer Focus, Creativity and a Competitive Focus. Astellas strives to be the company of choice among all our stakeholders, including our customers, our shareholders, our employees, and the global community. To achieve this goal, we will go beyond all others in exploring and tapping the potential of the life sciences and by supporting healthy living for people around the world. Our Business Philosophy is to contribute toward improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.

At BD, we are committed to helping all people live healthy lives. BD (Becton, Dickinson and Company) is a global medical technology company focused on improving drug therapy, enhancing the diagnosis of infectious diseases, and advancing drug discovery. BD manufactures and sells medical supplies, devices, laboratory instruments, antibodies, reagents and diagnostic products through its three segments: BD Medical, BD Diagnostics and BD Biosciences. We serve healthcare institutions, life science researchers, clinical laboratories, industry, and the general public. BD is headquartered in the United States and has offices in nearly 50 countries worldwide.

Agilent Technologies Life Sciences and Chemical Analysis (LSCA) is a leading provider of instrumentation, supplies, software and services to the life sciences. Agilent’s 25,000+ customers range from global pharmaceutical corporations to biotech companies, government labs and academic researchers. With $1.4 billion in revenue, Agilent LSCA has 4,100 employees worldwide and provides global sales, support and manufacturing. LSCA’s major sites are located in California, Delaware, Shanghai, Tokyo and Germany. Agilent tools help scientists to understand complex biological processes, unlock the causes of disease and speed the discovery of new drugs. Agilent provides products for customer needs throughout the entire pharmaceutical value chain from basic research to drug manufacturing.

IPM is a non-profit product development partnership (PDP) established in 2002 to prevent HIV transmission by accelerating the development and availability of a safe and effective microbicide for use by women in developing countries. IPM is committed to providing women with an affordable and self-initiated HIV- prevention strategy to reduce the cycle of infection which has led to the deaths of more than 25 million people worldwide and orphaned more than 15 million children since 1981. Like the promise of a future AIDS vaccine, microbicides represent an essential component of an integrated and comprehensive global response to the HIV/AIDS epidemic.

Sanofi pasteur is the largest company in the world devoted entirely to vaccines. Each year, we produce more than 1.4 billion doses of vaccine, making it possible to protect 500 million people across the globe, which is about 1.4 million per day. The company offers the broadest range of vaccines, providing protection against 20 bacterial and viral diseases. During the 2004-2005 Influenza season, sanofi pasteur was the sole supplier of injectable influenza vaccine to the US market. We believe there is still much work to be done. As the vaccines business of the sanofi-aventis Group, the world’s third largest pharmaceutical company, we have access to the resources needed to continue our boundary-breaking innovations far into the future. Come join a company making a strong impact on world health.

MGI PHARMA, INC. is an oncology and acute care focused biopharmaceutical company that acquires, develops and commercializes proprietary products that address the unmet needs of patients. MGI PHARMA has a portfolio of proprietary pharmaceuticals, and intends to become a leader in oncology and acute care. MGI PHARMA markets Aloxi® (palonosetron hydrochloride) injection, Kadian® (sustained release morphine sulfate) capsules, Salagen® Tablets (pilocarpine hydrochloride) and Hexalen® (altretamine) capsules in the United States. The Company directly markets its products in the U.S. and collaborates with partners to reach international markets.MGI PHARMA is based near Minneapolis, Minnesota, and its common stock is traded on The Nasdaq Stock Market® under the symbol MOGN.

Millennium is committed to making a difference in people's lives by developing breakthrough treatments for important diseases. Our researchers focus on serious disorders, examining in minute detail every step of the disease process to discover the underlying mechanisms at work, and to determine how those mechanisms may differ from one person to another. With this knowledge, we hope to provide patients with the most effective medicines for them, ensuring that they receive the right drugs, directed toward the right disease targets. We call this approach Personalized Medicine. At Millennium we set the highest standards of performance, behavior, and responsibility, both for ourselves as individuals and for the Company as a whole. Our standards today are the same as they were when the Company was founded, as reflected in our core values, and we back up those words with actions, as evidenced with our emphasis on corporate and social responsibility.

At Novartis, our performance-oriented culture and responsible approach are the foundations of our success. We recognize that our business depends on the creativity, dedication and performance of our associates. We encourage associates to focus on achievement through collaboration and innovation. A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented, performance driven people. All of which makes us one of the most rewarding employers in our field. Our products are concentrated in major therapeutic areas: Cardiovascular & Metabolism, Oncology & Hematology, Neuroscience, Respiratory, Infectious Diseases, Transplantation & Immunology (IDTI), Ophthalmics, Dermatology, Gastrointestinal, Urinary (ODGU) & Arthritis & Bone, We have received 15 new pharmaceutical product approvals in the US since 2000, the most of any pharmaceutical company.

Teva Pharmaceuticals USA is a leading generic pharmaceutical company, marketing products from a wide range of therapeutic areas including analgesic, anti-infective, cardiovascular, oncology, CNS, dermatological and anti-inflammatory. Dosage forms include extended and immediate release tablets and capsules, injectables, creams, ointments, solutions, and suspensions. Teva USA products are marketed to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. Teva Pharmaceuticals USA is a leading generic pharmaceutical company, marketing products from a wide range of therapeutic areas including analgesic, anti-infective, cardiovascular, oncology, CNS, dermatological and anti-inflammatory.

UBC is committed to attracting, developing, and retaining the industry’s most talented scientists and life sciences professionals. UBC provides challenging professional opportunities where high performance, teamwork, scientific expertise, and professional excellence are expected and rewarded. We prepare our teams to work side-by-side with industry experts and a broad array of client stakeholders and health care professionals. UBC is dedicated to building a deep understanding of our clients and their businesses as we strive to identify the best solutions to address their needs. Our success begins with our people, which is why UBC offers competitive compensation and benefits packages to help employees manage enriching professional careers and enjoy fulfilling personal lives.

Bausch & Lomb is the eye health company dedicated to perfecting vision and enhancing life. We offer the world’s most comprehensive portfolio of eye health products and we’re proud that ours is one of the oldest, best known and most respected healthcare brands in the world. We began in 1853 in Rochester, New York, as a small optical shop that grew to become a multi-billion dollar corporation with nearly 14,000 employees worldwide, and with products available in more than 100 countries.

eResearchTechnology, Inc. (eRT) is a provider of technology-based products and services that enable the pharmaceutical, biotechnological, medical device, and contract resource companies to collect, interpret, and distribute cardiac safety and clinical data more efficiently. The Company is a market leader in providing centralized electrocardiographic (diagnostic) services and a leading provider of technology and services designed to streamline the clinical trial process by enabling its customers to automate many parts of a clinical trial.

MAP Pharmaceuticals uses proprietary inhalation technologies to enhance the therapeutic benefits and commercial attractiveness of proven drugs while minimizing risk by capitalizing on their known safety, efficacy and commercialization history. We have several product candidates in development that address large market opportunities, including our two most advanced product candidates, Unit Dose Budesonide (UDB) for pediatric asthma and MAP0004 for migraine. Our technologies enable us to develop proprietary drug candidates for delivery via the respiratory tract to more effectively treat both local respiratory and systemically treatable diseases. We create inhalable drug particles with the specific physical and chemical characteristics to facilitate efficient pulmonary delivery.

The National Institute of Allergy and Infectious Diseases (NIAID), part of the world-renowned National Institutes of Health, strives to understand, treat, and ultimately prevent the myriad of infectious, immunologic, and allergic diseases. We seek to match ideal candidates with numerous positions as we assimilate unprecedented funding and mobilize science to protect public health. Whether you are a scientist, nurse, health specialist, or have a background in other support disciplines such as finance, communications, and administration, your individual talents are needed to support our mission. Build your career at NIAID and work with some of the most talented investigators in this country and abroad who are committed to improve global health in the 21st century. The DHHS, NIH, NIAID offers unique training and career building opportunities, competitive salaries and a comprehensive benefits package.

Aris Global is a global provider of software solutions and consultancy services to assist life sciences organizations to maintain regulatory compliance, manage and mitigate risk and improve operational efficiency. We have more than 15 years of industry experience and currently work with over 100 customers in the pharmaceutical, biotech, medical device and related industries. Our solutions cover Pharmacovigilance & Safety, Regulatory Affairs, Clinical Research and Medical Information, and represent the most comprehensive range available in the industry. Each solution in the suite aims to be 'best in class'; designed to meet the individual needs of corporate and regional departments. But when deployed together, they offer a unique opportunity to enable collaboration between departments, eliminating unnecessary duplication while reducing delays and improving compliance.

Celsis International plc is a world leading provider of innovative life science products and laboratory services to the pharmaceutical, biopharmaceutical, and consumer products industries through its three business areas; rapid detection, analytical and drug development services and ADME-Tox in vitro technologies. The company is listed on the London Stock Exchange (CEL.L). Each division of Celsis International plc has the capacity to deliver substantial time and cost savings to its customers, in addition to ensuring product quality and safety for consumers. Using proprietary technology, the Celsis Rapid Detection division provides diagnostic systems for the rapid detection of contamination.These systems provide significant economic value by reducing the time it takes to test and release raw materials, in process and finished goods to market. Celsis Analytical Services division provides cost effective outsourced laboratory testing services to pharmaceutical and biopharmaceutical companies.

Encorium is a full-service Contract Research Organization (CRO) providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development. Our teams are intimately familiar with the nuances of complex study design and the conduct of clinical trials from pre-clinical development through to phase IV and post marketing. Whether you require support for your early phase development plan, superior responsive project management and clinical site monitoring, advanced biostatistical support, practical, efficient solutions to data management issues or world-class medical/scientific consultancy, Encorium has the right people and resources to accelerate your product development.

As a global leader in healthcare, we are committed to offering our customers the very best life-enhancing products. As an employer, we’re equally intent on attracting and retaining the very best people. People who believe in creating a better future, and have the skills, energy and imagination to achieve it. Being one of the major employers in the pharmaceutical industry, we offer our dedicated professionals the scope, freedom and support to make things happen. Talented people from every background around the globe have the opportunity to exchange insights and expertise freely – across different specialties and different countries. However diverse their perspectives and backgrounds, our employees share a common belief—that we can make the future better in our continuous quest to help millions of people lead longer, healthier and happier lives.

Here at Merck, we rally around the statement made in 1950 by George W. Merck, the son of our founder, - "We try never to forget that medicine is for the people. It is not for the profits." And so, we're looking for people who will help us carry out our mission - preserving and improving human life.Our business is preserving and improving human life. All of our actions must be measured by our success in achieving this goal. We value, above all, our ability to serve everyone who can benefit from the appropriate use of our products and services, thereby providing lasting consumer satisfaction. We are committed to the highest standards of ethics and integrity. We are responsible to our customers, to Merck employees and their families, to the environments we inhabit, and to the societies we serve worldwide. In discharging our responsibilities, we do not take professional or ethical shortcuts.

At the New Schering-Plough, we aspire to earn the trust of doctors, patients and customers by providing a steady flow of innovative, science-based medicines and services that improve the health and well-being of people around the world. To achieve these goals and grow our company, we are working to earn the trust of all stakeholders. We understand that earning trust demands hard work, sharp execution, integrity and transparency. Our customers and patients are our most important constituents. Our vision for the New Schering-Plough clearly sets forth what we will do as a global team, what makes us special as a company and what will give us a competitive advantage.

Schering-Plough Animal Health Corporation's goal is to help keep animals healthy and help make your business more efficient and profitable. It is a commitment to excellence that dates back to our beginnings. With our facilities worldwide, we constantly monitor the emerging diseases and develop new technologies which help to maintain an animal's health. In fact, Schering-Plough Animal Health spends millions of dollars on research and development in a single year. This financial commitment supports our philosophy of growth through research. This has contributed to Schering-Plough Animal Health being recognized globally as an innovator and manufacturer of world class vaccines and pharmaceuticals.

Stryker is a broadly based, global leader in medical technology that consistently delivers exceptional results. We are one of the largest players in the $28.6 billion worldwide orthopaedic market and our products improve medical professionals’ and patients’ lives in over 120 countries. We are a company that sets high standards. Our growth has come from offering an unparalleled variety of innovative, high-quality products and services resulting from the dedication of our employees. Through better products, simplified surgical techniques and improved hospital efficiencies, we are reducing health-care costs in systems throughout the world and helping patients regain their active lives.

Virginia Bioinformatics Institute (VBI), a Commonwealth of Virginia shared resource established at Virginia Tech in July 2000, serves as a flagship bioinformatics research institute wedding cutting-edge biological research with state-of-the-art computer science. Used synergistically in a diversified research portfolio, these tools catalyze new knowledge and economic development for the Commonwealth of Virginia and beyond. The Institute's esteemed faculty and staff encourage research collaboration to increase the understanding of molecular, cellular, and environmental interactions that affect human health, agricultural systems, and the environment.